NeoCare Nordic ApS: Financial statements 2025
CVR: 43707795
Source: annual report 2025, Danish Business Authority
01/06/2024 – 31/05/2025
NeoCare Nordic ApS (CVR 43707795) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 914,419 and a net result of DKK -129,404. Equity in the 2025 report amounted to DKK 2,828,486. The solvency ratio was 50.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 914,419
- Profit/Loss
- DKK -129,404
- Equity
- DKK 2,828,486
- Total Assets
- DKK 5,561,138
- Employees
- 2
Official annual report
How creditworthy is NeoCare Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of February 3, 2025, VitalDeSign Medical ApS is registered as an owner of NeoCare Nordic ApS with an ownership share of 33%.
About NeoCare Nordic ApS
NeoCare Nordic ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named CareFold ApS. The management consists of Kristine Kuni Buccoliero. The board consists of Thea Olesen (chair), Finn Ketler and Rolf Singer. The company is owned by C.C.HOLDING 2000 A/S, VitalDeSign Medical ApS and Ohmega Holding ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK 914,419 and a net result of DKK -129,404. Equity in the 2025 report amounted to DKK 2,828,486.
